Sutro Biopharma, Inc. Common Stock (STRO) Stock
Key stats
- Market cap
- $170.12M
- Price / Earnings ratio
- -0.9x
- EPS (TTM)
- -$17.36
- Volume
- Loading
- 52-week high
- $43.85
- 52-week low
- $0.72
Source: third-party data provider, as of November 13, 2026
Compare with STRO
Recent news
Down 39.8% in 4 Weeks, Here's Why Sutro Biopharma (STRO) Looks Ripe for a Turnaround
Down 39.8% in 4 Weeks, Here's Why Sutro Biopharma (STRO) Looks Ripe for a Turnaround
STRO
STRO Stock Plummets 15% — What Drove The Selloff?
STRO Stock Plummets 15% — What Drove The Selloff?
STRO
Gilead-Tubulis $5B Deal Gives STRO Stock A Boost — Here’s Why
Gilead-Tubulis $5B Deal Gives STRO Stock A Boost — Here’s Why
STRO
7 Triple-F-Rated Stocks That Have No Hope in Sight
7 Triple-F-Rated Stocks That Have No Hope in Sight
STRONews tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 42.43
- MACD 12/26/9
- -1.08
- EMA 9 of MACD
- -1.47
- MACD histogram
- 0.38
- SMA 50
- $13.61
- Price below SMA 50
- EMA 50
- $13.55
- Price below EMA 50
- SMA 200
- $22.81
- Price below SMA 200
- EMA 200
- $18.52
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news
Down 39.8% in 4 Weeks, Here's Why Sutro Biopharma (STRO) Looks Ripe for a Turnaround
Down 39.8% in 4 Weeks, Here's Why Sutro Biopharma (STRO) Looks Ripe for a Turnaround
STROSTRO Stock Plummets 15% — What Drove The Selloff?
STRO Stock Plummets 15% — What Drove The Selloff?
STROGilead-Tubulis $5B Deal Gives STRO Stock A Boost — Here’s Why
Gilead-Tubulis $5B Deal Gives STRO Stock A Boost — Here’s Why
STRO7 Triple-F-Rated Stocks That Have No Hope in Sight
7 Triple-F-Rated Stocks That Have No Hope in Sight
STRONews tone: automated (AI) classification of the article's content, not a price prediction.
About Sutro Biopharma, Inc. Common Stock
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. Company's wholly-owned product candidate is STRO-004, a single homogeneous ADC directed against tissue factor which are developing for the treatment of solid tumors. The company also pipeline contains STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Ms. Jane Chung R.Ph. | CEO & Director | 1971 |
| Mr. Gregory K. Chow BA, CPA, MBA | Chief Financial Officer | 1973 |
| Dr. Hans-Peter Gerber Ph.D. | Chief Scientific Officer | 1964 |
| Dr. James R. Swartz DSc, Ph.D., Sc.D. | Founder | — |
| Mr. Devendra Luhar | Senior Vice President of Technical Operations | — |
| Mr. David Pauling J.D., M.A. | Chief Administrative Officer & General Counsel | 1974 |
| Ms. Kari E. Leetch | Senior VP and Head of People & Culture | — |
| Mr. Jonathan Fawcett DPHIL, MBBS | VP & Head of Clinical Development | — |
| Ms. Regina Cheng | Vice President & Controller | — |
Fundamentals
Valuation
Profitability
Trading
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 42.43
- MACD 12/26/9
- -1.08
- EMA 9 of MACD
- -1.47
- MACD histogram
- 0.38
- SMA 50
- $13.61
- Price below SMA 50
- EMA 50
- $13.55
- Price below EMA 50
- SMA 200
- $22.81
- Price below SMA 200
- EMA 200
- $18.52
- Price below EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
1 analyst rating
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $34.00
- Average
- $47.00
- High
- $60.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -24.8 | -19.4 | -22.6 | -43.0 | +12.6 |
